Real-world experience of ocrelizumab in MS in the Turkish population: A single-center study

Koc, E.Saridas, F.Ceylan, D.Turan, O.Ozkaya, G.2024-09-292024-09-2920221351-51011468-1331https://hdl.handle.net/20.500.14619/8726[No abstract available]eninfo:eu-repo/semantics/closedAccessReal-world experience of ocrelizumab in MS in the Turkish population: A single-center studyConference Object79279229WOS:000815254003320Q1